B Norris, V Angeles, R Eisenstein, JP Seale - The Annals of pharmacotherapy, 2006 - Harvey Whitney Books 2260 I The Annals of Pharmacotherapy I 2006 December, Volume 40 ... Neuroleptic
malignant syndrome (NMS) is a potentially life-threatening complication of
antipsychotic medica- tions. Symptoms of NMS can manifest at the onset of ... Cited by 3 - Related articles - BL Direct - All 4 versions
- ►czresearch.com [PDF] LA Copeland, EM Mortensen, JE Zeber, MJ … - Progress in Neuropsychopharmacology & Biological …, 2007 - Elsevier Among decedents, 943 (3%) had schizophrenia, 3% were women, most were white
(76%) or African–American (18%), and average age at death was 72.4 years (SD
11.5). Three-fifths received VA outpatient care in the year prior to death. ... Cited by 2 - Related articles - All 5 versions
JD Baird, LG Arroyo, M Vengust, MKJ … - Journal of the American Veterinary Medical Association, 2006 - Am Vet Med Assoc Clinical Findings—Clinical signs included restlessness, agitation, profuse
sweating, hypermetria, aimless circling, intense pawing and striking with the
thoracic limbs, and rhythmic swinging of the head and neck alternating with ... Cited by 2 - Related articles - BL Direct - All 7 versions
AO Varoglu, O Ates, OL Gundogdu, A Aksoy, … - The world journal of biological psychiatry: the official …, 2007 - ncbi.nlm.nih.gov Neuroleptic malignant syndrome (NMS) is a rare clinical condition and
potentially life-threatening complication of antipsychotic medications. We
report a patient with an atypical presentation of NMS. A 60-year-old man ... Cited by 1 - Related articles - All 2 versions